ES2062310T3
(es)
|
1989-12-06 |
1994-12-16 |
Akzo Nv |
Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado.
|
EP0813873B1
(en)
|
1996-06-19 |
2002-02-13 |
Akzo Nobel N.V. |
Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
|
EP1829539A3
(en)
|
1996-11-05 |
2008-02-20 |
HEADEXPLORER ApS |
A method for treating tension-type headache
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
CN1154495C
(zh)
|
1997-11-14 |
2004-06-23 |
阿克佐诺贝尔公司 |
米氮平用于治疗睡眠性呼吸暂停的用途
|
EP1066036B1
(en)
|
1998-02-27 |
2006-04-26 |
The Board Of Trustees Of The University Of Illinois |
Agents with serotonin-related activity for the treatment for sleep apnea
|
PT1067934E
(pt)
|
1998-04-02 |
2004-03-31 |
Akzo Nobel Nv |
Solucao anti-depressiva liquida oral
|
US6211171B1
(en)
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
RU2001128228A
(ru)
|
1999-04-19 |
2003-07-20 |
Тева Фармасьютикал Индастриз Лтд. (Il) |
Новый синтез пиперазинового кольца
|
AU781221B2
(en)
|
1999-04-19 |
2005-05-12 |
Teva Pharmaceutical Industries Ltd. |
Novel synthesis and crystallization of piperazine ring-containing compounds
|
US6245782B1
(en)
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
CN1355698A
(zh)
|
1999-06-15 |
2002-06-26 |
呼吸器有限公司 |
可用作治疗有关支气管收缩的机能障碍的药物的化合物
|
US6281207B1
(en)
|
1999-09-15 |
2001-08-28 |
Reed Richter |
Treatment of movement disorders by administration of mirtazapine
|
TWI256309B
(en)
|
1999-10-13 |
2006-06-11 |
Akzo Nobel Nv |
New formulation of mirtazapine
|
WO2001038329A1
(fr)
|
1999-11-24 |
2001-05-31 |
Sumika Fine Chemicals Co., Ltd. |
Cristaux de mirtazapine anhydre et leur procede d'obtention
|
WO2001042239A1
(fr)
|
1999-12-13 |
2001-06-14 |
Sumika Fine Chemicals Co., Ltd. |
Procede de preparation d'un compose pyridinemethanol
|
US20050074487A1
(en)
|
1999-12-16 |
2005-04-07 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
IL150290A0
(en)
|
2000-02-11 |
2002-12-01 |
Akzo Nobel Nv |
The use of mirtazapine for the treatment of sleep disorders
|
US7678387B2
(en)
|
2000-06-06 |
2010-03-16 |
Capricorn Pharma, Inc. |
Drug delivery systems
|
US6375982B1
(en)
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
US20020072602A1
(en)
|
2000-07-07 |
2002-06-13 |
Claude Singer |
Micronized mirtazapine
|
US7074961B2
(en)
|
2000-09-26 |
2006-07-11 |
The Brigham And Women's Hospital, Inc. |
Antidepressants and their analogues as long-acting local anesthetics and analgesics
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
US6660730B2
(en)
|
2000-11-27 |
2003-12-09 |
Sumika Fine Chemicals Co., Ltd. |
Anhydrous mirtazapine and process for preparing the same
|
DE60224078T2
(de)
|
2001-02-12 |
2008-12-04 |
N.V. Organon |
Verwendung von Mirtazapin zur Verbesserung der Behandlung von Menschen mit starken Depressionen, welche Träger des Gens für Apolipoprotein E4 sind.
|
KR20030078086A
(ko)
|
2001-03-01 |
2003-10-04 |
테바 파마슈티컬 인더스트리즈 리미티드 |
미르타자핀 중간체의 제조방법
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
ITMI20011446A1
(it)
|
2001-07-06 |
2003-01-06 |
Altergon Sa |
Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
|
WO2007064311A1
(en)
|
2001-07-10 |
2007-06-07 |
Teva Pharmaceutical Industries Ltd. |
Micronized mirtazapine
|
DE10153078A1
(de)
|
2001-10-30 |
2003-05-22 |
Degussa |
Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
|
EP1941878A1
(en)
|
2002-01-10 |
2008-07-09 |
Biovail Laboratories International Srl |
Sedative non-benzodiazepine formulations
|
AU2003213787A1
(en)
|
2002-03-06 |
2003-09-22 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
US20030194420A1
(en)
|
2002-04-11 |
2003-10-16 |
Richard Holl |
Process for loading a drug delivery device
|
FR2842734A1
(fr)
|
2002-07-24 |
2004-01-30 |
Ethypharm Sa |
Procede pour diminuer la variabilite de la biodisponibilite d'un medicament a administration orale et compositions pharmaceutiques a administration orale
|
US20120156144A1
(en)
|
2002-10-25 |
2012-06-21 |
Foamix |
Foamable Compositions, Kits and Methods for Hyperhidrosis
|
US20040146551A1
(en)
|
2002-11-01 |
2004-07-29 |
Biodelivery Sciences International, Inc. |
Geodate delivery vehicles
|
US20050013845A1
(en)
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
US20040192754A1
(en)
|
2003-03-24 |
2004-09-30 |
Shapira Nathan Andrew |
Methods for treating idiopathic hyperhidrosis and associated conditions
|
US7749533B2
(en)
|
2003-05-07 |
2010-07-06 |
Akina, Inc. |
Highly plastic granules for making fast melting tablets
|
US7041826B2
(en)
|
2003-06-02 |
2006-05-09 |
Aurobindo Pharma Ltd. |
Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate
|
UA83666C2
(ru)
|
2003-07-10 |
2008-08-11 |
Н.В. Органон |
Способ получения энантиомерно чистого миртазапина
|
AU2003903597A0
(en)
|
2003-07-11 |
2003-07-24 |
Jakov Vaisman |
Treatment of premature ejaculation
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
US7838029B1
(en)
|
2003-07-31 |
2010-11-23 |
Watson Laboratories, Inc. |
Mirtazapine solid dosage forms
|
AU2004264974A1
(en)
|
2003-08-15 |
2005-02-24 |
Arius Two, Inc. |
Adhesive bioerodible transmucosal drug delivery system
|
US20050112196A1
(en)
|
2003-10-07 |
2005-05-26 |
Jianbo Xie |
Rapidly disintegrating formulation
|
EP1689371A2
(en)
|
2003-11-25 |
2006-08-16 |
Aurobindo Pharma Limited |
Pharmaceutical compositions of mirtazapine
|
WO2005063213A1
(en)
|
2003-12-19 |
2005-07-14 |
Biodelivery Sciences International, Inc. |
Rigid liposomal cochleate and methods of use and manufacture
|
US7713959B2
(en)
|
2004-01-13 |
2010-05-11 |
Duke University |
Compositions of an anticonvulsant and mirtazapine to prevent weight gain
|
WO2005089511A2
(en)
|
2004-03-19 |
2005-09-29 |
Transform Pharmaceuticals, Inc. |
Novel pharmaceutical forms, and methods of making and using the same
|
TW200538100A
(en)
|
2004-04-21 |
2005-12-01 |
Akzo Nobel Nv |
Mirtazapine salts
|
DE102004034043A1
(de)
|
2004-07-13 |
2006-02-09 |
Krka Tovarna Zdravil, D.D. |
Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
|
ES2246161B1
(es)
|
2004-07-22 |
2007-04-01 |
Medichem, S.A. |
Proceso mejorado para la fabricacion de mirtazapina.
|
EP1776121A2
(en)
|
2004-08-13 |
2007-04-25 |
Omeros Corporation |
Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists
|
US20060127479A1
(en)
|
2004-10-08 |
2006-06-15 |
Natrajan Kumaraperumal |
Solvent free taste masked pharmaceutical compositions
|
TW200631584A
(en)
|
2004-11-15 |
2006-09-16 |
Akzo Nobel Nv |
A medicament related to mirtazapine for the treatment of hot flush
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8512751B2
(en)
|
2004-12-20 |
2013-08-20 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical compositions for sleep disorders
|
KR100822519B1
(ko)
|
2005-02-15 |
2008-04-16 |
주식회사종근당 |
위장 내에서 제어방출되는 단일 매트릭스 정제
|
KR20080012896A
(ko)
|
2005-04-27 |
2008-02-12 |
유엠엔 파마 아이엔씨 |
췌장염 예방 및 치료제
|
US20090306046A1
(en)
|
2005-06-27 |
2009-12-10 |
N.V. Organon |
Method of treatment of hormone depletion induced vasomotor symptoms
|
CA2613875C
(en)
|
2005-07-04 |
2018-09-25 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
WO2007012154A1
(en)
|
2005-07-27 |
2007-02-01 |
Carlos Henrique Horta Lima |
Pharmaceutical preparation containing an acetylcholinesterase ihibitor and an antidepressant with 5-ht and alpha-2-adrenoceptor blocking properties.
|
WO2007019880A1
(en)
|
2005-08-18 |
2007-02-22 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Use of a selective inhibitor of norepinephrine reuptake for treating respiratory disorders resulting from rett syndrome
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
CN102126978A
(zh)
|
2005-09-26 |
2011-07-20 |
住友化学株式会社 |
光学活性的哌嗪化合物的制造方法
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
US20080287774A1
(en)
|
2005-11-06 |
2008-11-20 |
Rachel Katz-Brull |
Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof
|
WO2007057508A2
(en)
|
2005-11-18 |
2007-05-24 |
Orion Corporation |
Treatment of pain with a combination of an alpha2 -adrenoceptor antagonist such as atipemezole or fipamezoiie and an opioid receptor agonist, such as tramadol
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
BRPI0618918B8
(pt)
|
2005-11-22 |
2021-05-25 |
Nalpropion Pharmaceuticals Llc |
uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
|
EP1792618A1
(en)
|
2005-11-30 |
2007-06-06 |
Rainer Freynhagen |
R-mirtazapine for the treatment of pain
|
US7541371B2
(en)
|
2006-02-20 |
2009-06-02 |
Eisai R&D Management Co., Ltd. |
Method for treating a motor neuron disease
|
WO2007101832A1
(en)
|
2006-03-06 |
2007-09-13 |
N.V. Organon |
An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
|
FR2900339B1
(fr)
|
2006-04-28 |
2008-07-25 |
Univ Claude Bernard Lyon I Eta |
Utilisation d'un compose qui induit une augmentation du taux de serotonine libre dans l'organisme, pour la preparation d'un medicament destine a traiter des degenerescences du muscle squelettique
|
TW200808804A
(en)
|
2006-05-22 |
2008-02-16 |
Organon Nv |
Mirtazapine for the treatment of neuropathic pain
|
US20070270413A1
(en)
|
2006-05-22 |
2007-11-22 |
N.V. Organon |
Mirtazapine for the treatment of neuropathic pain
|
US20080118553A1
(en)
|
2006-06-12 |
2008-05-22 |
Anton Frenkel |
Tannate salt form of polypeptide mixtures, their preparation and use
|
DE102006027792A1
(de)
|
2006-06-16 |
2007-12-20 |
Lts Lohmann Therapie-Systeme Ag |
Antidepressiva-Kombinations-Wafer
|
US20080014252A1
(en)
|
2006-07-14 |
2008-01-17 |
Delprete Keith |
Topical compositions with long lasting effect
|
WO2008060397A2
(en)
|
2006-11-03 |
2008-05-22 |
Noven Therapeutics, Llc |
Method of treating thermoregulatory disfunction
|
AU2007324467A1
(en)
|
2006-11-22 |
2008-05-29 |
N.V. Organon |
Vaginal delivery system for mirtazapine
|
US20100016322A1
(en)
|
2007-02-28 |
2010-01-21 |
Nagesh Nagaraju |
Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
JP5192707B2
(ja)
|
2007-03-22 |
2013-05-08 |
住友化学株式会社 |
ミルタザピンの製造方法
|
CN101679431B
(zh)
|
2007-04-11 |
2013-08-14 |
Msd欧斯股份有限公司 |
制备四环苯并氮杂卓的对映异构体的方法
|
US7994314B2
(en)
|
2007-04-11 |
2011-08-09 |
N.V. Organon |
Method for the preparation of an enantiomerically pure benzazepine
|
US20080255348A1
(en)
|
2007-04-11 |
2008-10-16 |
N.V. Organon |
Method for the preparation of an enantiomer of a tetracyclic benzazepine
|
CN101679420B
(zh)
|
2007-04-11 |
2014-05-14 |
默沙东有限责任公司 |
一种制备对映体纯的苯并氮杂*的方法
|
WO2009018088A2
(en)
|
2007-08-01 |
2009-02-05 |
Link Medicine Corporation |
Imaging of alpha-synuclein
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
CA2704117C
(en)
|
2007-11-02 |
2015-11-17 |
Acrux Dds Pty Ltd |
Transdermal delivery system
|
JP5547096B2
(ja)
|
2008-02-28 |
2014-07-09 |
アール.ピー. シェーラー テクノロジーズ エルエルシー |
多型を最小化する方法
|
EP2344498A1
(en)
|
2008-10-22 |
2011-07-20 |
Watson Pharma Private Limited |
Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
|
WO2010081036A2
(en)
|
2009-01-09 |
2010-07-15 |
President And Fellows Of Harvard College |
Fluorine containing compounds and methods of use thereof
|
WO2010148519A1
(en)
|
2009-06-25 |
2010-12-29 |
Queen's University At Kingston |
Methods and therapies for alleviating pain comprising an ultra low dose of an alpha 2 receptor antagonist
|
WO2011091050A1
(en)
|
2010-01-19 |
2011-07-28 |
Nektar Therapeutics |
Oligomer-tricyclic conjugates
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
EP2377522B1
(en)
|
2010-04-15 |
2013-01-16 |
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi |
Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
|
CA3071911C
(en)
|
2010-08-23 |
2023-01-17 |
Darren Rubin |
Systems and methods of aerosol delivery with airflow regulation
|
DE102010049706A1
(de)
|
2010-10-28 |
2012-05-03 |
Hexal Ag |
Herstellung orodispersibler Filme
|
WO2012077651A1
(ja)
|
2010-12-07 |
2012-06-14 |
祐徳薬品工業株式会社 |
ノルアドレナリン作動性・特異的セロトニン作動性抗うつ薬含有経皮吸収型貼付製剤
|
EP2508174A1
(en)
|
2011-04-06 |
2012-10-10 |
Ljiljana Sovic Brkicic |
Pharmaceutical composition
|
GB2503187A
(en)
|
2011-09-15 |
2013-12-25 |
Univ Sussex |
Composition for use in the treatment of neurodevelopmental disorders
|
US20130274247A1
(en)
|
2012-04-17 |
2013-10-17 |
Jessica Quimby |
Mirtazapine as an Appetite Stimulant for Cats
|
WO2013183407A1
(ja)
|
2012-06-05 |
2013-12-12 |
祐徳薬品工業株式会社 |
ミルタザピン含有経皮吸収型貼付製剤
|
EP2690102A1
(en)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bicyclic aza-amides for treatment of psychiatric disorders
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
US20140271727A1
(en)
|
2013-03-18 |
2014-09-18 |
National Yang-Ming University |
Method of using an antidepressant for increasing immunity of a subject and treating cancer
|
EA201592236A1
(ru)
|
2013-06-04 |
2016-06-30 |
Вайом Байосайнсиз Пвт. Лтд. |
Частицы с нанесенным покрытием и композиции, включающие такие частицы
|
EP2856934A1
(en)
|
2013-10-04 |
2015-04-08 |
Les Laboratoires Servier |
Biomarkers for the prediction of long term remission in depression
|
GB201320675D0
(en)
|
2013-11-22 |
2014-01-08 |
Univ Nottingham |
Composition
|
WO2015085004A1
(en)
|
2013-12-03 |
2015-06-11 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
FR3015289B1
(fr)
|
2013-12-20 |
2017-01-13 |
Virbac |
Mirtazapine injectable
|